These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26453208)

  • 1. Analyzing Tau Aggregation with Electron Microscopy.
    Huseby CJ; Kuret J
    Methods Mol Biol; 2016; 1345():101-12. PubMed ID: 26453208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and Quantification Methods for Fibrillar Products of In Vitro Tau Aggregation Assays.
    Nanavaty N; Lin L; Hinckley SH; Kuret J
    Methods Mol Biol; 2017; 1523():101-111. PubMed ID: 27975246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular "light switch" [Ru(phen)2dppzidzo](2+) monitoring the aggregation of tau.
    Gao X; Wang L; Huang HL; Wang LL; Yao JL; Shi S; Yao TM
    Analyst; 2015 Nov; 140(22):7513-7. PubMed ID: 26460552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
    Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
    Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein anatomy: C-tail region of human tau protein as a crucial structural element in Alzheimer's paired helical filament formation in vitro.
    Yanagawa H; Chung SH; Ogawa Y; Sato K; Shibata-Seki T; Masai J; Ishiguro K
    Biochemistry; 1998 Feb; 37(7):1979-88. PubMed ID: 9485325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryo-EM structures of tau filaments from Alzheimer's disease.
    Fitzpatrick AWP; Falcon B; He S; Murzin AG; Murshudov G; Garringer HJ; Crowther RA; Ghetti B; Goedert M; Scheres SHW
    Nature; 2017 Jul; 547(7662):185-190. PubMed ID: 28678775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils.
    Marreiro A; Van Kolen K; Sousa C; Temmerman L; Vasconcelos B; Crespo-Rodriguez R; van Weering JRT; Van Dam D; De Deyn PP; Apetri A; Schoofs L; Mercken MH
    BMC Mol Cell Biol; 2020 Nov; 21(1):81. PubMed ID: 33183222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating triggers and enhancers of tau fibrillization.
    Kuret J; Congdon EE; Li G; Yin H; Yu X; Zhong Q
    Microsc Res Tech; 2005 Jul; 67(3-4):141-55. PubMed ID: 16103995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments.
    Jeganathan S; von Bergen M; Mandelkow EM; Mandelkow E
    Biochemistry; 2008 Oct; 47(40):10526-39. PubMed ID: 18783251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for an intermediate in tau filament formation.
    Chirita CN; Kuret J
    Biochemistry; 2004 Feb; 43(6):1704-14. PubMed ID: 14769048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro.
    Rane JS; Bhaumik P; Panda D
    J Alzheimers Dis; 2017; 60(3):999-1014. PubMed ID: 28984591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis.
    von Bergen M; Barghorn S; Müller SA; Pickhardt M; Biernat J; Mandelkow EM; Davies P; Aebi U; Mandelkow E
    Biochemistry; 2006 May; 45(20):6446-57. PubMed ID: 16700555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct microscopic mechanisms for the accelerated aggregation of pathogenic Tau mutants revealed by kinetic analysis.
    Yao QQ; Hong L; Wu S; Perrett S
    Phys Chem Chem Phys; 2020 Apr; 22(14):7241-7249. PubMed ID: 32207466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cysteines in accelerating Tau filament formation.
    Chidambaram H; Chinnathambi S
    J Biomol Struct Dyn; 2022 Jul; 40(10):4366-4375. PubMed ID: 33317395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tau domain-specific antibodies and intravenous immunoglobulin on tau aggregation and aggregate degradation.
    Esteves-Villanueva JO; Trzeciakiewicz H; Loeffler DA; Martić S
    Biochemistry; 2015 Jan; 54(2):293-302. PubMed ID: 25545358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregation Kinetics and Filament Structure of a Tau Fragment Are Influenced by the Sulfation Pattern of the Cofactor Heparin.
    Townsend D; Fullwood NJ; Yates EA; Middleton DA
    Biochemistry; 2020 Oct; 59(41):4003-4014. PubMed ID: 32954725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A curcumin-based molecular probe for near-infrared fluorescence imaging of tau fibrils in Alzheimer's disease.
    Park KS; Seo Y; Kim MK; Kim K; Kim YK; Choo H; Chong Y
    Org Biomol Chem; 2015 Dec; 13(46):11194-9. PubMed ID: 26488450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau peptides and tau mutant protein aggregation inhibition by cationic polyethyleneimine and polyarginine.
    Nadimidla K; Ismail T; Kanapathipillai M
    Biopolymers; 2017 Sep; 107(9):. PubMed ID: 28456996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudo-phosphorylation of tau at Ser202 and Thr205 affects tau filament formation.
    Rankin CA; Sun Q; Gamblin TC
    Brain Res Mol Brain Res; 2005 Jul; 138(1):84-93. PubMed ID: 15913837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A static laser light scattering assay for surfactant-induced tau fibrillization.
    Necula M; Kuret J
    Anal Biochem; 2004 Oct; 333(2):205-15. PubMed ID: 15450794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.